Chiron Group has sold a minority stake to KYIP Capital

Milan – CFI is pleased to announce that it acted as exclusive financial advisor to Chiron Group, a national provider of radiological and outpatient healthcare services, regarding KYIP Capital’s acquisition of a 36% stake.

Based in Turin, Chiron operates through two business lines: outsourced radiological services for over thirty healthcare facilities, and a network of nine outpatient centers across Northern and Central Italy. The transaction involved a dedicated capital increase to support Chiron’s growth strategy, including targeted acquisitions and the strengthening of the Group’s operational platform.

The investment aims to accelerate the Group’s expansion and enhance geographic coverage and diagnostic capacity.

Eugenio Conforti, Partner and Head of Investments at KYIP Impact Mission Fund, commented:

“Chiron is a solid and scalable platform addressing a key healthcare need: strengthening regional diagnostics to improve prevention, early diagnosis, and access to care. This investment will support structured growth through both organic development and selective acquisitions.”

Andrea Cicchiello, CEO of Chiron Group, added:

“We founded Chiron to offer accessible, high-quality healthcare. With KYIP alongside us, we aim to scale nationally and accelerate growth through targeted acquisitions, while continuing to reduce inequalities and ensure timely, sustainable care.”

This transaction closed on 24 February 2026.